Teva to pay New York $500M for role in opioid crisis - POLITICO
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Here's Why Teva Pharma Stock Is Soaring Today
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment? - Simply Wall St News
Teva Pharmaceuticals - Wikipedia
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva looks to amp up research collaborations, CEO says
Teva CEO stands down during troubled times - MedCity News
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Should You Sell Teva Pharmaceutical Industries Ltd (TEVA) Stock Friday Morning?
Teva Pharmaceutical Industries says it'll close Bucks Co. plant in 2017 | Business News | wfmz.com
